Helicobacter pylori infection and PD‐L1 expression in gastric cancer: A meta‐analysis
European Journal of Clinical Investigation · 2023-02 · 53 (2)
DOI: 10.1111/eci.13880 ↗Kurz gefasst
Metaanalyse in der Zeitschrift European Journal of Clinical Investigation, online erschienen am 26.10.2022. Verfasst von Yaodong Zhu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrated Traditional and Western Medicine in Oncology, The First Affiliated Hospital of Medical University of Anhui, Hefei, China. Hauptthemen laut MEDLINE: B7-H1 Antigen, Helicobacter Infections, Stomach Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Cancer Research Fund of CSPC PHARMA, Natural Science Foundation of the Anhui Higher Education Institutions of China, The Special Fund for Clinical Research of Wu Jieping Medical Foundation.
Abstract (Originalsprache)
Background
High expression of programmed death ligand‐1 (PD‐L1) has been related to good response to immunotherapy patients with gastric cancer (GC). However, the influence of Helicobacter pylori (HP) infection on PD‐L1 expression in GC remains unknown. A meta‐analysis was performed to evaluate the association between HP infection and PD‐L1 expression in GC.
Methods
Observational studies that investigated the relationship between HP infection and PD‐L1 expression in patients with GC were obtained by search electronic databases, including PubMed, Embase, Cochrane's Library and Web of Science. A random‐effect model incorporating the possible influence of between‐study heterogeneity was used to pool the results.
Results
Ten studies with 1870 patients with GC contributed to the meta‐analysis. Pooled results showed that HP infection was significantly associated with the tumour expression of PD‐L1 (odds ratio [OR]: 1.90, 95% confidence interval: 1.33–2.72, p < .001; I 2 = 53%). Subgroup analyses showed that the association between HP infection and PD‐L1 expression in GC was not significantly affected by sample size, methods for PD‐L1 evaluation and quality score ( p for subgroup analyses all >.05). However, a stronger association was observed in studies with higher prevalence of HP infection (≥35%, OR: 2.58) as compared with those with lower prevalence (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Integrated Traditional and Western Medicine in Oncology, The First Affiliated Hospital of Medical University of Anhui, Hefei, China.
ORCID-Profile: Yaodong Zhu
Förderung
- Cancer Research Fund of CSPC PHARMA
- Natural Science Foundation of the Anhui Higher Education Institutions of China
- The Special Fund for Clinical Research of Wu Jieping Medical Foundation
Zitieren
APA
Zhu, Y., Zhu, F., Ba, H., Chen, J., & Bian, X. (2023). Helicobacter pylori infection and PD‐L1 expression in gastric cancer: A meta‐analysis. European Journal of Clinical Investigation, 53(2). https://doi.org/10.1111/eci.13880
Vancouver
Zhu Y, Zhu F, Ba H, Chen J, Bian X. Helicobacter pylori infection and PD‐L1 expression in gastric cancer: A meta‐analysis. European Journal of Clinical Investigation. 2023;53(2). doi:10.1111/eci.13880
BibTeX
@article{Zhu2023,
author = {Zhu, Yaodong and Zhu, Fangyuan and Ba, He and Chen, Jie and Bian, Xiuliang},
title = {Helicobacter pylori infection and PD‐L1 expression in gastric cancer: A meta‐analysis},
journal = {European Journal of Clinical Investigation},
year = {2023},
volume = {53},
number = {2},
doi = {10.1111/eci.13880}
}
EUVIMED